AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Geisinger at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Geisinger brings 2 presentations to AMP 2026 in Seattle. Its sessions cover molecular diagnostics for pancreatic lesions, and how testing sharpens care for patients whose disease is hard to see. It also joins a listening session on artificial intelligence in molecular pathology.
| Organization | AMP 2026 Attendance |
|---|---|
Geisinger Danville, PA | |
Health system in central Pennsylvania that runs the MyCode population genomic screening programme alongside its hospitals and clinics. | Workshop Thu, Nov 12 3:45pm–4:15pm AI in Molecular Pathology: Your Voice, Our Future A listening session where attendees help shape AMP's AI position statement on responsible use, workforce, data, regulation and reimbursement. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. |
Find decision makers at Geisinger
Tell us what you sell and we’ll find the people at Geisinger most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction